76 Millions of people in the United States are alive today because of advancements in cancer screening, prevention, and treatment. A major new study has revealed that nearly six million deaths from five of the most common cancers have been avoided over the past 45 years, largely due to early detection efforts and public health campaigns. The findings were published in the journal JAMA Oncology. The study analysed data spanning from 1975 to 2020 and focused on breast, cervical, colorectal, lung, and prostate cancers. Together, these cancers account for around half of all US cancer diagnoses and deaths. Researchers used detailed modelling to estimate how many lives were saved compared to a scenario where no advances in prevention, screening, or treatment had been made. The findings highlight the overwhelming impact of public health initiatives. Prevention and screening were responsible for averting 80% of the deaths, according to the study. In particular, lung cancer prevention through tobacco control played a pivotal role, accounting for 3.45 million of the 5.94 million deaths avoided. This underscores the lasting legacy of smoking cessation campaigns and tighter regulations around tobacco use. Screening programmes also had significant results across other cancer types. Cervical cancer saw virtually all its averted deaths credited to screening measures such as the Pap smear and HPV testing. Colorectal cancer deaths were prevented mostly through screening and early polyp removal, while prostate cancer outcomes benefited from prostate-specific antigen testing. Although breast cancer remains one of the most common types, its pattern differed. Only 25% of the 1.03 million breast cancer deaths averted were linked to screening. The majority were attributed to improved treatment options developed during the study period, such as chemotherapy, targeted therapy, and hormonal treatments. This reflects the success of clinical innovations in managing this particular cancer type once diagnosed. Despite the positive results, the researchers emphasised that the US still has considerable work to do if it is to reach new targets such as the Cancer Moonshot goal of halving cancer mortality by 2047. Uptake of some screening interventions, such as those for lung cancer, remains low, and disparities in access continue to pose a challenge. The study also noted that certain cancers with high death rates, such as pancreatic and liver cancer, were not included in the analysis because population models for those cancers are still developing. The research did not examine harms associated with screening or prevention strategies, such as false positives or the psychological and financial burdens of overdiagnosis. However, the overall trend points clearly to the life-saving power of detecting and preventing cancer before it becomes untreatable. Experts say the findings support continued investment in public health, especially campaigns that promote early screening, healthy behaviours, and access to proven treatments. As researchers call for wider adoption of effective interventions and the development of new tools, the results serve as a reminder of how much progress has already been made – and how much more could be achieved.
Millions of people in the United States are alive today because of advancements in cancer screening, prevention, and treatment. A major new study has revealed that nearly six million deaths from five of the most common cancers have been avoided over the past 45 years, largely due to early detection efforts and public health campaigns. The findings were published in the journal JAMA Oncology. The study analysed data spanning from 1975 to 2020 and focused on breast, cervical, colorectal, lung, and prostate cancers. Together, these cancers account for around half of all US cancer diagnoses and deaths. Researchers used detailed modelling to estimate how many lives were saved compared to a scenario where no advances in prevention, screening, or treatment had been made. The findings highlight the overwhelming impact of public health initiatives. Prevention and screening were responsible for averting 80% of the deaths, according to the study. In particular, lung cancer prevention through tobacco control played a pivotal role, accounting for 3.45 million of the 5.94 million deaths avoided. This underscores the lasting legacy of smoking cessation campaigns and tighter regulations around tobacco use. Screening programmes also had significant results across other cancer types. Cervical cancer saw virtually all its averted deaths credited to screening measures such as the Pap smear and HPV testing. Colorectal cancer deaths were prevented mostly through screening and early polyp removal, while prostate cancer outcomes benefited from prostate-specific antigen testing. Although breast cancer remains one of the most common types, its pattern differed. Only 25% of the 1.03 million breast cancer deaths averted were linked to screening. The majority were attributed to improved treatment options developed during the study period, such as chemotherapy, targeted therapy, and hormonal treatments. This reflects the success of clinical innovations in managing this particular cancer type once diagnosed. Despite the positive results, the researchers emphasised that the US still has considerable work to do if it is to reach new targets such as the Cancer Moonshot goal of halving cancer mortality by 2047. Uptake of some screening interventions, such as those for lung cancer, remains low, and disparities in access continue to pose a challenge. The study also noted that certain cancers with high death rates, such as pancreatic and liver cancer, were not included in the analysis because population models for those cancers are still developing. The research did not examine harms associated with screening or prevention strategies, such as false positives or the psychological and financial burdens of overdiagnosis. However, the overall trend points clearly to the life-saving power of detecting and preventing cancer before it becomes untreatable. Experts say the findings support continued investment in public health, especially campaigns that promote early screening, healthy behaviours, and access to proven treatments. As researchers call for wider adoption of effective interventions and the development of new tools, the results serve as a reminder of how much progress has already been made – and how much more could be achieved.